NCT05137769

Brief Summary

PTSD develops after trauma and is marked by intrusive memories, avoidance of reminders, negative changes in mood and cognitive processes, and dysregulated physical and emotional stress reactivity. PTSD disparately affects twice as many women as men (8.0% vs. 4.1%), and finding effective treatments for these women is critical to reduce poor health outcomes associated with PTSD. Mind-body therapies (MBT), using the mind in combination with the body to facilitate healing hold promise to enhance PTSD treatment by improving stress regulation. While MBT reduce PTSD symptoms long-term, women with PTSD may initially experience distress, leading to treatment avoidance. This pilot study will explore women's initial responses to MBT, the prevalence of adverse responses, and which women are at risk for adverse responses in a sample of participants with a history of trauma and varying levels of PTSD symptoms. Study participants will attend one virtual study visit via one-on-one videoconference with the PI, where they will complete self-report measures of stress and affect before and after one session of a MBT exercise. A subset of the sample will complete a semi-structured individual videoconference interview with the PI within two weeks following completion of the MBT exercise and quantitative measures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 15, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 30, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

April 15, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2023

Completed
Last Updated

February 3, 2023

Status Verified

February 1, 2023

Enrollment Period

10 months

First QC Date

November 15, 2021

Last Update Submit

February 1, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in Positive Affect

    Positive affect will be measured with The Positive and Negative Affect Schedule-Short Form (PANAS-SF), a 20-item questionnaire with 10 items assessing positive affect and 10 items assessing negative affect. Participants will be asked to "indicate to what extent you feel this way right now, that is, at the present moment" on a five-point scale; 1 = very slightly or not at all, 2 = a little, 3 = moderately, 4 = quite a bit and 5 = extremely. The positive affect score is obtained by adding the scores on items 1, 3, 5, 9, 10, 12, 14, 16, 17 and 19. The range of the possible total score is 10-50 with higher scores indicating greater positive affect.

    Baseline to 1-minute post body scan

  • Change in Negative Affect

    Negative affect will be measured with The Positive and Negative Affect Schedule-Short Form (PANAS-SF), a 20-item questionnaire with 10 items assessing positive affect and 10 items assessing negative affect. Participants will be asked to "indicate to what extent you feel this way right now, that is, at the present moment" on a five-point scale; 1 = very slightly or not at all, 2 = a little, 3 = moderately, 4 = quite a bit and 5 = extremely. The negative affect score is obtained by adding the scores on items 2, 4, 6, 7, 8, 11, 13, 15, 18 and 20. The range of the possible scores is 10-50 with higher scores indicating greater negative affect.

    Baseline to 1-minute post body scan

  • Change in State Anxiety

    State anxiety will be measured with The State-Trait Anxiety Inventory-State Form (STAI-S), a 20-item questionnaire with equal numbers of anxiety-present (e.g., "I feel tense") and anxiety-absent descriptors (e.g., "I feel calm"). Participants will be asked to indicate " how you feel right now, that is, at this moment" on a four-point scale; 1= not at all, 2 = somewhat, 3 = moderately so, 4= very much so. The anxiety-absent items (1, 2, 5, 8, 10, 11, 15, 16, 19, 20) will be reverse scored, and then all 20-items will be summed to obtain the state anxiety score. The range of the possible scores is 20-80; higher scores indicate greater state anxiety.

    Baseline to 1-minute post body scan

  • Participant Experience (qualitative)

    A subset of the sample (n=20) will complete a one-on-one telephone semi-structured interview to understand participant's perceived experience of the body scan exercise.

    2 weeks post the in-person study visit.

Study Arms (1)

Body Scan

EXPERIMENTAL

Participants will listen to a 20-minute, audio-guided mindfulness-based body scan exercise.

Behavioral: Body Scan

Interventions

Body ScanBEHAVIORAL

The body scan is a core element of mindfulness-based stress reduction. Participants will listen to a 20-minute audio guide instructing them to focus on sensations in the body, place attention on one area of the body at a time, and progressively move attention throughout areas of the body.

Body Scan

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsSelf-identify as a woman and were assigned female sex at birth
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Previously experienced a traumatic event as defined by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) \>6 months prior,
  • self-identify as a woman and were assigned female sex at birth,
  • \>18 years of age,
  • fluency in English,
  • access to computer or smartphone to complete REDCap surveys and videoconference study visit.

You may not qualify if:

  • active suicidal thoughts with a plan,
  • unable to abstain from drugs or alcohol for \>48 hours prior to study videoconference,
  • current or history of psychosis with auditory and/or visual hallucinations,
  • meditated or practiced yoga \>1 time(s) per month over past 6 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Center of Hope

Columbia, Tennessee, 38402, United States

Location

Ascension Medical Group St Thomas Nashville

Nashville, Tennessee, 37203, United States

Location

Sterling Primary Care Associates - Centennial

Nashville, Tennessee, 37203, United States

Location

Empowered Heart

Nashville, Tennessee, 37204, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticPsychological Trauma

Interventions

Whole Body Imaging

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Study Officials

  • Hannah G Nolte, PhD(C)

    Vanderbilt University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Candidate, Principal Investigator

Study Record Dates

First Submitted

November 15, 2021

First Posted

November 30, 2021

Study Start

April 15, 2022

Primary Completion

February 1, 2023

Study Completion

February 1, 2023

Last Updated

February 3, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations